National Commission on Scleroderma and Fibrotic Diseases Act of 2018 This bill temporarily establishes a National Commission on Fibrotic Diseases within the National Institutes of Health that must recommend improvements regarding fibrosis and fibrotic disease research.
Advisory bodiesCongressional oversightGovernment studies and investigationsHealth programs administration and fundingHealth promotion and preventive careMedical researchMedical tests and diagnostic methodsMusculoskeletal and skin diseasesOrgan and tissue donation and transplantationResearch administration and fundingResearch and development
A bill to establish a National Commission on Fibrotic Diseases.
USA115th CongressS-3267| Senate
| Updated: 7/25/2018
National Commission on Scleroderma and Fibrotic Diseases Act of 2018 This bill temporarily establishes a National Commission on Fibrotic Diseases within the National Institutes of Health that must recommend improvements regarding fibrosis and fibrotic disease research.
Advisory bodiesCongressional oversightGovernment studies and investigationsHealth programs administration and fundingHealth promotion and preventive careMedical researchMedical tests and diagnostic methodsMusculoskeletal and skin diseasesOrgan and tissue donation and transplantationResearch administration and fundingResearch and development